11.08.2011 • News

K+S Group Net Income Down, Earnings from Continued Operations Up

K+S Group reported net income for the second quarter of €28.7 million, over €76.4 million last year. Earnings per share dropped to €0.15 from €0.40 a year ago.

Earnings from continued operations rose to €126.2 million or €0.66 per share from €64.7 million or €0.34 per share in the prior year quarter.

Adjusted earnings from continued operations were €126.8 million or €0.66 per share, compared to €85.9 million or €0.45 per share last year.

Operating earnings before interest and taxes climbed 38% year-over-year to €191.9 million from €138.9 million a year ago.

Quarterly revenues also jumped to €1.05 billion from €948.1 million in the previous year.

"Thanks to our strong fertilizer business we were able to significantly increase revenues and earnings of the K+S Group also in the second quarter compared to the previous year," said Chairman Norbert Steiner.

Looking forward, the company now anticipates full-year adjusted earnings per share from continued operations between €3.40 and €3.75 and revenues of €5 billion and €5.30 billion.

 

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read